Reported Reactions

Devices › Implant, endosseous, root-form

Device brand name · Endosseous dental implant

BL, ? 3.3mm NC, SLActive 10mm, TiZr, NTP: medical device reports filed with FDA

7,001 reports name it, 2019–2026. Manufacturer given most often on reports: Institut Straumann. Product code DZE.

7,001
device reports naming the brand
0% of all MAUDE reports · about 1,025 a year
786
reports, 12 months to August 2026
870 in the 12 months before
0%
classified as malfunction
0.8% across the product code
0%
classified as death, as reported
0 reports · not verified by FDA

7,001 medical device reports received by FDA name the brand "BL, ? 3.3mm NC, SLActive 10mm, TiZr, NTP" (endosseous dental implant); the manufacturer given most often on reports is Institut Straumann; received from September 2019 to August 2026. Brand names are as the reporter or manufacturer wrote them, so one product can appear under several spellings.

786 reports arrived in the 12 months to August 2026, down 10% from 870 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (100%); across all implant, endosseous, root-form reports (product code DZE) death is recorded in 0% and malfunction in 0.8%. Event type is the reporter's classification of the report, not a verified outcome.

The device problems coded most often are failure to osseointegrate (66.9%), loss of osseointegration (24.2%) and fracture (3.5%). The patient problems coded most often are fibrosis, pain and tissue damage. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Reports by month, five years

099197Sep 2021: 83Oct 2021: 91Nov 2021: 92Dec 2021: 752022Jan 2022: 104Feb 2022: 55Mar 2022: 102Apr 2022: 86May 2022: 119Jun 2022: 65Jul 2022: 59Aug 2022: 90Sep 2022: 76Oct 2022: 105Nov 2022: 87Dec 2022: 1022023Jan 2023: 65Feb 2023: 82Mar 2023: 67Apr 2023: 91May 2023: 112Jun 2023: 105Jul 2023: 98Aug 2023: 93Sep 2023: 76Oct 2023: 101Nov 2023: 77Dec 2023: 812024Jan 2024: 86Feb 2024: 69Mar 2024: 96Apr 2024: 101May 2024: 85Jun 2024: 78Jul 2024: 77Aug 2024: 102Sep 2024: 75Oct 2024: 70Nov 2024: 82Dec 2024: 832025Jan 2025: 55Feb 2025: 70Mar 2025: 78Apr 2025: 41May 2025: 0Jun 2025: 197Jul 2025: 54Aug 2025: 65Sep 2025: 62Oct 2025: 74Nov 2025: 61Dec 2025: 672026Jan 2026: 67Feb 2026: 59Mar 2026: 72Apr 2026: 67May 2026: 75Jun 2026: 55Jul 2026: 49Aug 2026: 78

Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

By year received

05251,0502019: 74320192020: 81220202021: 99820212022: 1,05020222023: 1,04820232024: 1,00420242025: 82420252026: 5222026

Event type and report source

Event type, as classified on the report

Death0%0
Injury100%7,001
Malfunction0%0
Other0%0
Not given0%0

Who filed the report

Manufacturer report86.3%6,040
Voluntary report0%0
User facility report0%0
Distributor report13.7%961
Not given0%0

Grey bar: all 3,924,241 reports carrying product code DZE. Event type is the filer's classification and is not verified by FDA.

Device problems coded

Device problem (FDA code)ReportsShareShare across product code
Failure to osseointegrate4,68266.9%62.8%
Loss of osseointegration1,69524.2%22.4%
Fracturea broken bone2463.5%1.6%
Difficult to insertthe device was hard to insert490.7%0.4%
Unintended movement90.1%0%
Unstable60.1%0%
Separation failure50.1%0.1%
Activation, positioning or separation problem20%0%
Defective devicethe device was defective10%0%
Positioning problem10%0.1%
Therapeutic or diagnostic output failure10%0%

FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.

Patient problems coded

Patient problem (FDA code)ReportsShare
Fibrosis1,99128.4%
Painpain, site not specified1,22117.4%
Tissue damage95513.6%
Inflammationinflammation6499.3%
Hemorrhage/blood loss/bleeding3705.3%
Swelling/ edema3394.8%
Fistula2523.6%
Abscessa collection of pus2163.1%
Hyperresponsive to stimuli1311.9%
Failure of implant921.3%
Swellingswelling751.1%
Hypersensitivity/allergic reaction681%
Inadequate osseointegration290.4%
Increased sensitivity280.4%
Sinus perforation220.3%

Patient problem codes are present mainly in reports filed since 2019 and are often blank.

In context

MeasureBL, ? 3.3mm NC, SLActive 10mm, TiZr, NTPProduct code DZEAll MAUDE reports
Reports7,0013,924,24126,136,888
Share of that pool—0.2%0%
Classified as death, per 1,000 reports009
Classified as injury100%99.2%36.2%
Classified as malfunction0%0.8%62.3%
Filed by the manufacturer86.3%77.7%94.9%

Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Other brands with product code DZE

BrandReportsLatest 12 monthsClassified as death
Biohorizons Dental Implant58,73200%
BioHorizons Inc.57,02025,5360%
NobelActive Internal RP 4.3x10mm49,0989,5280%
BLT ?4.1mm RC, SLA? 10mm, TiZr, Loxim45,6509,6770%
NobelParallel CC RP 4.3x10mm44,2699,3180%
BLT ?4.1mm RC, SLActive? 10mm, TiZr, NTP41,6727,5310%
Unknown Implant39,9671,4540%
NobelReplace CC RP 4.3x10mm35,9468,1660%
NobelReplace CC PMC RP 4.3x10mm34,4478,6900%
NobelActive Internal RP 4.3x11.5mm33,1175,7040%
BLT ?3.3mm NC, SLA? 10mm, TiZr, Loxim28,6485,6950%
BLT ?4.1mm RC, SLA? 10mm, Ti, Loxim26,7248,4810%
BLT ?3.3mm NC, SLActive? 10mm, TiZr, NTP26,5404,6800%
NobelActive Internal RP 4.3x13mm25,5563,7640%
BLT ?4.1mm RC, SLA? 8mm, TiZr, Loxim24,7725,9780%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."

Questions about BL, ? 3.3mm NC, SLActive 10mm, TiZr, NTP reports

How many FDA reports name BL, ? 3.3mm NC, SLActive 10mm, TiZr, NTP?

7,001 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 786 in the latest 12 months.

What kinds of events are reported?

injury (100%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.

What device problems are coded?

failure to osseointegrate (66.9%), loss of osseointegration (24.2%), fracture (3.5%), difficult to insert (0.7%) and unintended movement (0.1%). These are FDA's device problem codes as entered on the report.

Who files these reports?

manufacturer reports (86.3%) and distributor reports (13.7%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.

Do these reports show that BL, ? 3.3mm NC, SLActive 10mm, TiZr, NTP was at fault?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."

How do I report a problem with a medical device?

Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.